UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study

Journal of the European Academy of Dermatology and Venereology, 2018-03, Vol.32 (3), p.403-410

2018

Volltextzugriff (PDF)

Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study

British journal of dermatology (1951), 2016-04, Vol.174 (4), p.770-777

2016

Volltextzugriff (PDF)

Phase 3, open‐label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector in patients with moderate‐to‐severe plaque psoriasis (UNCOVER‐A)

Journal of the European Academy of Dermatology and Venereology, 2017-01, Vol.31 (1), p.107-113

2017

Volltextzugriff (PDF)

A seamless phase I/II dose‐finding trial assessing ingenol disoxate (LEO 43204) for field treatment of actinic keratosis on the scalp

British journal of dermatology (1951), 2017-06, Vol.176 (6), p.1456-1464

2017

Volltextzugriff (PDF)

Efficacité et tolérance du risankizumab dans le psoriasis en plaques modéré à sévère : résultats à 16 semaines de l’étude Immhance

Annales de dermatologie et de vénéréologie, 2018-12, Vol.145 (12), p.S355-S356

2018

Volltextzugriff (PDF)

Photodynamic therapy with methyl aminolaevulinate 80 mg g−1 for severe facial acne vulgaris: a randomized vehicle-controlled study

British journal of dermatology (1951), 2016-04, Vol.174 (4), p.770-777

2016

Volltextzugriff (PDF)

Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience

Medical devices (Auckland, N.Z.), 2016-01, Vol.9, p.361-369

2016

Volltextzugriff (PDF)

The utility of clinical examination in screening for pelvic fractures in blunt trauma

Journal of the American College of Surgeons, 2002-02, Vol.194 (2), p.121-125

2002

Volltextzugriff (PDF)

Role of clinical examination in screening for blunt cervical spine injury

Journal of the American College of Surgeons, 1999-08, Vol.189 (2), p.152-157

1999

Volltextzugriff (PDF)

Structure systématique de la flore endémique dans la région de Central Black Earth Zone en relation avec sa subdivision floristique à l'intérieur des districts

Botanic̆eskij z̆urnal, 1989, Vol.74 (5), p.638-650

BUKHALO, M. A

1989

Volltextzugriff (PDF)

Leukocytoclastic vasculitis induced by use of glyburide: A case of possible cross-reaction of a sulfonamide and a sulfonylurea

Cutis (New York, N.Y.), 2003-03, Vol.71 (3), p.224-225

2003

Volltextzugriff (PDF)

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

The New England journal of medicine, 2017-03, Vol.376 (9), p.826-835

2017

Volltextzugriff (PDF)

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

The New England journal of medicine, 2016-07, Vol.375 (4), p.345-356

2016

Volltextzugriff (PDF)

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

British journal of dermatology (1951), 2020-06, Vol.182 (6), p.1348-1358

2020

Volltextzugriff (PDF)

Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study

British journal of dermatology (1951), 2023-09, Vol.189 (4), p.392-399

2023

Volltextzugriff (PDF)

Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial

JAMA dermatology (Chicago, Ill.), 2022-05, Vol.158 (5), p.533

2022

Volltextzugriff (PDF)

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial

JAMA dermatology (Chicago, Ill.), 2023-06, Vol.159 (6), p.613

2023

Volltextzugriff (PDF)

Randomized Vehicle-Controlled Study of Short Drug Incubation Aminolevulinic Acid Photodynamic Therapy for Actinic Keratoses of the Face or Scalp

Dermatologic surgery, 2016-03, Vol.42 (3), p.296-304

2016

Volltextzugriff (PDF)

STATE SUPPORT FOR AGRICULTURAL SECTOR AND ITS IMPACT TO FORM RESULTS INDICES OF THE ACTIVITIES AT BRANCH ENTERPRISES

Fìnansovo-kreditna dìâlʹnìstʹ: problemi teorìì̈ ta praktiki (Online), 2019-06, Vol.2 (29), p.487-495

2019

Volltextzugriff (PDF)

Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study

Dermatology and therapy, 2024-11

2024

Volltextzugriff (PDF)

Efficacy and safety of ingenol disoxate gel in field treatment of actinic keratosis on full face, scalp or large area (250 cm2) on the chest: results of four phase 3 randomized controlled trials

Dermatology online journal, 2020-10, Vol.26 (10)

2020

Volltextzugriff (PDF)

EFFECT TO CROP ROTATION AND FERTILIZATION SYSTEM IN YIELD AND TECHNOLOGICAL QUALITY IN SUGAR BEET (BETA VULGARIS L.)

PLANT ARCHIVES, 2021-04, Vol.21 (1)

2021

Volltextzugriff (PDF)

Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials

Journal of drugs in dermatology, 2016-05, Vol.15 (5), p.553

2016

Volltextzugriff (PDF)

Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial

Journal of drugs in dermatology, 2013-01, Vol.12 (1), p.92

2013

Volltextzugriff (PDF)

Once-daily roflumilast foam 0.3% for scalp and body psoriasis: A randomized, double-blind, vehicle-controlled phase 2b study

British journal of dermatology (1951), 2023-06

2023

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(27)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Humans
(15)
Dermatology
(14)
Female
(12)
Male
(12)
Adult
(11)
Middle Aged
(9)
Double-Blind Method
(7)
Treatment Outcome
(7)
Adolescent
(6)
Aged
(6)
Clinical Trials
(6)
Psoriasis
(6)
Psoriasis - Drug Therapy
(5)
Severity Of Illness Index
(5)
Monoclonal Antibodies
(4)
Aged, 80 And Over
(3)
Antibodies, Monoclonal, Humanized - Adverse Effects
(3)
Biological And Medical Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study

Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study

Phase 3, open‐label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector in patients with moderate‐to‐severe plaque psoriasis (UNCOVER‐A)

A seamless phase I/II dose‐finding trial assessing ingenol disoxate (LEO 43204) for field treatment of actinic keratosis on the scalp

Efficacité et tolérance du risankizumab dans le psoriasis en plaques modéré à sévère : résultats à 16 semaines de l’étude Immhance

Photodynamic therapy with methyl aminolaevulinate 80 mg g−1 for severe facial acne vulgaris: a randomized vehicle-controlled study

Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience

The utility of clinical examination in screening for pelvic fractures in blunt trauma

Role of clinical examination in screening for blunt cervical spine injury

Structure systématique de la flore endémique dans la région de Central Black Earth Zone en relation avec sa subdivision floristique à l'intérieur des districts

Leukocytoclastic vasculitis induced by use of glyburide: A case of possible cross-reaction of a sulfonamide and a sulfonylurea

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study

Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial

Randomized Vehicle-Controlled Study of Short Drug Incubation Aminolevulinic Acid Photodynamic Therapy for Actinic Keratoses of the Face or Scalp

STATE SUPPORT FOR AGRICULTURAL SECTOR AND ITS IMPACT TO FORM RESULTS INDICES OF THE ACTIVITIES AT BRANCH ENTERPRISES

Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study

Efficacy and safety of ingenol disoxate gel in field treatment of actinic keratosis on full face, scalp or large area (250 cm2) on the chest: results of four phase 3 randomized controlled trials

EFFECT TO CROP ROTATION AND FERTILIZATION SYSTEM IN YIELD AND TECHNOLOGICAL QUALITY IN SUGAR BEET (BETA VULGARIS L.)

Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials

Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial

Once-daily roflumilast foam 0.3% for scalp and body psoriasis: A randomized, double-blind, vehicle-controlled phase 2b study

Suchergebnisse filtern